The 2-Minute Rule for what kind of drug is nembutal
The 2-Minute Rule for what kind of drug is nembutal
Blog Article
pentobarbital decreases levels of ponatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Steer clear of Except the coadministration outweighs the probable possibility of ponatinib underexposure; check for indications of decreased efficacy.
pentobarbital will decrease the extent or impact of bexarotene by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lower the extent or outcome of hydrocortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will reduce the level or impact of oxybutynin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.
pentobarbital decreases amounts of elvitegravir/cobicistat/emtricitabine/tenofovir DF by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May perhaps lead to lack of virologic reaction and achievable resistance.
Contraindicated (1)pentobarbital will minimize the extent or impact of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is accountable for the development and elimination of cariprazine's Lively metabolites.
pentobarbital will reduce the level or outcome of midazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
Missing your password? This web site makes use of cookies to provide you with an even better browsing expertise. By searching this Web page, you comply with our usage of cookies. Acknowledge
Monitor Carefully (1)pentobarbital will reduce the extent or influence of levamlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or impact of parecoxib by affecting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Watch.
pentobarbital will lower the extent or impact of itraconazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.
pentobarbital raises toxicity of buprenorphine, extensive-acting injection by pharmacodynamic synergism. Modify Therapy/Observe Closely. Coadministration of buprenorphine and benzodiazepines or other CNS depressants will increase possibility of adverse reactions like overdose, respiratory melancholy, and death. Cessation of benzodiazepines or other CNS depressants is desired usually.
pentobarbital will decrease the level or effect of efavirenz by impacting hepatic/intestinal enzyme click here CYP3A4 metabolism. Minimal/Importance Unidentified.
pentobarbital will lower the level or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a delicate CYP3A4 substrate. Coadministration with sturdy or reasonable CYP3A4 inducers is contraindicated.